A postulated role for 16α-hydroxydehydroepiandrosterone in the prevention of respiratory distress syndrome

Medical Hypotheses

Volumn 66, Issue 1, 2006, Pages 107-109

  Lardy, Henry ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYPRASTERONE; GLUCOCORTICOID; PRASTERONE; STEROID; UNCLASSIFIED DRUG;

AMNION FLUID; ARTICLE; BIRTH; BLOOD LEVEL; CONCENTRATION (PARAMETERS); DEVELOPMENTAL DISORDER; DRUG TOLERABILITY; FETUS LUNG MATURATION; GESTATIONAL AGE; HUMAN; INFANCY; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY DISTRESS SYNDROME;

AMNIOTIC FLUID; DEHYDROEPIANDROSTERONE; HUMANS; INFANT, NEWBORN; LUNG; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 27744580804     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.07.022     Document Type: Article

References (37)

1. K. Fotherby, A. Colas, S. Atherden, and G. Marrian The isolation of 16α-hydroxydehydroepiandrosterone (3β:16α-dihydroxyandrost-5- en-17-one) from the urine of normal men Biochem J 66 1957 664 669
2. H. Hirschmann Steroid excretion in a case of adrenocortical carcinoma. I The isolation of a Δ5-androstenetriol-3β,16,17 J Biol Chem 150 1943 363 379
3. G. Marrian, and G. Butler The isolation of a Δ5-androstene-3β, 16,17-triol from the urine of normal human males and females Biochem J 38 1944 322 324
4. S. Cohen, G. Marrian, and M. Watson Excretion of free oestrin during pregnancy Lancet 1 1935 674 676
5. R. Hobkirk, and M. Nilsen Six estrogen fractions in human pregnancy urine Acta Endocrinol Suppl. 51 1960 1111 Session560
6. G. Smith, and O. Smith Internal secretions and toxemia of late pregnancy Physiol Rev 28 1948 1 22
7. K. Ryan Metabolism of 16-oxygenated steroids by human placenta: the formation of estriol J Biol Chem 234 1959 2006 2008
8. H. Magendantz, and K. Ryan Isolation of an estriol precursor, 16α-hydroxydehydroepiandrosterone, from human umbilical sera J Clin Endocrinol 24 1964 1155 1162
9. A. Colas, W. Heinrichs, and H. Tatum Pettenkofer chromogens in the maternal and fetal circulations: detection of 3β,16α-dihydroxy- androst-5-en-17-one in umbilical cord blood Steroids 3 1964 417 434
10. W. Slaunwhite, M. Karsay, and A. Hollmer Fetal liver as an endocrine tissue Steroids 6 1965 211 221
11. J. Reynolds Excretion of 16α-hydroxy steroids by premature infants J Clin Endocrinol Metab 26 1966 1251 1256
12. W. Heinrichs, H. Feder, and A. Colas The steroid 16α-hydroxylase system in mammalian liver Steroids 7 1966 91 98
13. S. Solomon Formation and metabolism of neutral steroids in the human placenta or fetus J Clin Endocrinol Metab 26 1966 762 772
14. C. Shackleton, J.-A. Gustafsson, and F. Mitchell Steroids in newborns and infants: the changing pattern of urinary excretion during infancy Acta Endocrinol 74 1973 157 167
15. K. Ryan Conversion of Δ5-androstene-3β,16α,17β- triol to estriol by human placenta Endocrinology 63 1958 392 394
16. A. Rane, S. Henningsson, B. Ask, and M. Ladona Comparison of human fetal hepatic and adrenal cytochrome P450 activities with some major gestational steroids and ethylmorphine as substrates J Steroid Biochem Mol Biol 43 1992 335 341
17. S. Dell-Acqua, S. Mancuso, and G. Eriksson Studies on the aromatization of neutral steroids in pregnant women. 6. Aromatisation of 16α- hydroxylated C-19 steroids by midterm placentas perfused in situ Acta Endocrinol 55 1967 401 414
18. E. Young-Lai, and S. Solomon The in vivo metabolism of 16α-hydroxylated steroids in late pregnancy Biochemistry 7 1968 1881 1888
19. R. Hampl, and L. Starka Minireview: 16α-hydroxylated metabolites of dehydroepiandrosterone and their biological significance Endocr Regul 34 2000 161 163
20. J. Homoki, E. Roitman, and C. Shackleton Characterization of the major steroids present in amniotic fluid obtained between the 15th and 17th weeks of gestation J Steroid Biochem 19 1983 1061 1068
21. N. Tagawa, S. Kusuda, and Y. Kobayashi C16 hydroxylation of 3β-hydroxy-Δ5-steroids during the early neonatal period Biol Pharm Bull 20 1997 1295 1299
22. B. Salvadori, L. Benassi, and A. Merialdi Feto-neonatal hormonology in premature delivery J Steroid Biochem 8 1977 385 386
23. S. Kojima, T. Yanaihara, and T. Nakayama Serum steroid levels in children at birth and in early neonatal period Am J Obstet Gynecol 140 1981 961 965
24. T. Laatikainen, J. Peltonen, and P. Nylander Determination of estriol, estriolsulfate, progesterone and neutral steroid mono- and disulfates in umbilical cord plasma Steroids 21 1973 347 359
25. R. Cleary, and R. Pion Urinary excretion of 16α- hydroxydehydroepiandrosterone and 16-ketoandrostendiol during the early neonatal period J Clin Endocrinol Metab 28 1968 372 378
26. D. LaCroix, M. Sonnier, and A. Moncion Expression of CYP3A in the human liver. Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth Eur J Biochem 247 1997 625 634
27. G. Liggens, and R. Howie A controlled trial of antepartum glucocorticoid treatment for the prevention of the respiratory distress syndrome in premature infants Pediatrics 50 1972 515 525
28. P. Crowley, I. Chalmers, and M. Keirse The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials Brit J Obstet Gynaecol 97 1990 133
29. M. Baden, C. Bauer, and E. Colle A controlled trial of hydrocortisol therapy in infants wth respiratory distress syndrome J Pediatr 50 1972 526 534
30. T. Bhuta, and A. Ohlsson A systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease Arch Dis Child Fetal Neonatal Ed 79 1998 F26 F33
31. O. Benesova, and A. Pavlik Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain Neuropharmacology 28 1989 89 97
32. W. Tarnow-Mordi, and A. Mitra Postnatal dexamethasone in preterm infants is potentially life-saving, but follow-up studies are urgently needed Brit Med J 319 1999 1385 1386
33. A. Jobe, and M. Ikegami Mechanisms initiating lung injury in the preterm Early Hum Dev 53 1998 81 94
34. M. Weichsel The therapeutic use of glucocorticoid hormones in the perinatal period. Potential neurological hazards Ann Neurol 46 1977 364 366
35. H. Halliday Costs and benefits of perinatal corticosteroid treatment Prenat Neonat Med 5 2000 201 203
36. L. Doyle, P. Davis, and C. Morley Risks and benefits of steroids in preterm infants J Pediatr 138 2001 784 785
37. O. Baud Postnatal steroid treatment and brain development Arch Dis Child Fetal Neonat Ed 89 2004 F96 F100